Related Experiment Video
Updated: Sep 6, 2025
08:01
Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
Published on: April 21, 2022
2.0K
Immunotherapy approaches for malignant pleural mesothelioma
Dean A Fennell1, Sean Dulloo2, James Harber2,3
1Mesothelioma Research Programme, Centre for Cancer Research, University of Leicester & University of Leicester Hospitals NHS Trust, Leicester, UK. df132@leicester.ac.uk.
Nature Reviews. Clinical Oncology
|July 1, 2022
Summary
Immune-checkpoint inhibitors (ICIs) significantly improve survival for mesothelioma patients. Ongoing research explores novel combinations and non-ICI immunotherapies to further enhance cancer treatment efficacy.
Area of Science:
- Oncology
- Immunology
- Cancer Research
Background:
- Mesothelioma is a rare cancer with poor prognosis, often linked to asbestos exposure.
- Immune-checkpoint inhibitors (ICIs) have transformed cancer treatment, showing significant survival benefits in mesothelioma.
- Understanding predictive biomarkers for ICI response in mesothelioma is crucial.
Purpose of the Study:
- To review the development of immunotherapies for mesothelioma.
- To highlight strategies leading to clinical evaluation and identify response predictors.
- To forecast future treatment opportunities in mesothelioma immunotherapy.
Main Methods:
- Comprehensive review of clinical trials and research studies on mesothelioma immunotherapies.
- Analysis of immune microenvironment and genomic landscape data.
- Evaluation of ongoing combination therapies and novel non-ICI approaches.
Main Results:
- Single or dual ICIs demonstrate robust survival improvements in mesothelioma.
- Emerging insights into the immune microenvironment and genomics are associated with ICI response.
- Non-ICI immunotherapies like vaccines and CAR T-cells show promising efficacy.
Conclusions:
- ICIs have revolutionized mesothelioma treatment, offering improved survival.
- Further research into combination therapies and predictive biomarkers is essential.
- Future opportunities lie in novel immunotherapeutic strategies and personalized treatment approaches.
More Related Videos
Related Concept Videos
01:27Tumor Immunotherapy
652
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
652
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
01:30Pleural Disorders: Types and Brief Description
290
The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
290
02:49Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
02:17The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K